首页> 外国专利> NEW AMINOPHENYL-CYCLOAMIDINE DERIVATIVES, THEIR PRODUCTION AND THEIR MEDICINAL USE

NEW AMINOPHENYL-CYCLOAMIDINE DERIVATIVES, THEIR PRODUCTION AND THEIR MEDICINAL USE

机译:新的氨基苯并环糊精衍生物,其生产及其医药用途

摘要

1325528 Aminophenyl - cycloamidine derivatives BAYER AG 11 June 1971 [13 June 1970] 27494/71 Heading C2C Novel aminophenyl-cycloamidine derivatives (1) wherein R is a hydrogen atom or a straight or branched chain alkyl, alkenyl or alkynyl group, which can be substituted by a halogen atom or an alkoxy or hydroxy group; RSP2/SP is a -CORSP4/SP or -SO 2 RSP5/SP group [in which RSP4/SP is a hydrogen atom; a straight or branched chain alkyl, alkenyl, alkynyl, alkoxy, alkenyloxy, alkynyloxy, alkoxyalkoxy, alkoxyalkyl or alkoxy group, which can be substituted by a chlorine atom or by a hydroxy, cyano or oxo group; a cycloalkyl group or a cycloalkenyl group containing one or two double bonds, which groups can be substituted by one or more alkyl groups; a cycloalkylalkyl, tetrahydrofurfuryl, tetrahydrofuryl or tetrahydropyranyl group which can be substituted by one or more alkyl groups; a trifluoromethyl group; a carbalkoxyalkyl group; a cycloalkylalkoxy, cycloalkoxy, or tetrahydrofurylalkoxy group; a phenalkoxy, phenoxyalkoxy, phenoxy, phenylalkyl, phenyl or naphthyl group, the aromatic ring of which can be substituted by one or more alkyl, alkenyl, alkoxy, nitro, trifluoromethyl, cyano, alkylsulphonyl, acylamino and/or alkylsulphonylamino groups and/or halogen atoms; or a heteroaromatic O- and/or N-containing ring system; RSP5/SP is a straight or branched chain alkyl or alkenyl group; a cycloalkyl group; a phenylalkyl, phenyl or naphthyl group, the aromatic ring of which can be substituted by one or more alkyl, alkenyl, alkoxy, nitro, trifluoromethyl, cyano, acylamino, alkylsulphonyl and/or alkylsulphonylamino groups and/or chlorine, bromine or fluorine atoms]; RSP3/SP, RSP7/SP and RSP8/SP, which can be the same or different, are each a hydrogen or halogen atom or a straight or branchedchain alkyl, alkenyl or alkoxy group or a cyano or trifluoromethyl group; RSP6/SP and RSP9/SP, which can be the same or different, are each a hydrogen atom or an alkyl group; and n is 3, 4 or 5; and salts thereof may be prepared by (a) reacting a compound (3) with a lactam or thiolactam (4) in which W is oxygen or sulphur, or with a salt or a reactive derivative thereof especially a lactam; (b) reacting an imide chloride (6) with an amine RNH 2 ; (c) reacting an arylisocyanate (8) with a lactam (9) (d) reacting a carbamic acid chloride (10) with a lactam (9); (e) alkylating a compound (1) in which R is hydrogen with B-R in which B is a reactive ester group or a halogen, and R is as above except hydrogen; or (f) reacting an aminophenyl-cyclo-amidine (13) with an acylating or sulphonating agent RSP2/SPY where Y is a reactive ester group. The intermediate 2-(4-aminophenyl-imino)-1- methyl-pyrrolidine may be prepared by catalytic hydrogenation of 2 - (4 - nitrophenylimino)- 1-methyl pyrrolidine. Other listed intermediates may be prepared by known methods. Pharmaceutical compositions of the compounds (1) show parasiticide, especially antihelminthic, activity and some have antihypertensive activity when administered orally or parenterally alone or with the usual excipients.
机译:1325528氨基苯基-环am衍生物BAYER AG 1971年6月11日[1970年6月13日] 27494/71标题C2C新颖的氨基苯基-环am衍生物(1),其中R为氢原子或直链或支链的烷基,烯基或炔基,可以为被卤素原子或烷氧基或羟基取代; R 2 是-COR 4 或-SO 2 R 5 基团[其中R 4 是氢原子;直链或支链的烷基,烯基,炔基,烷氧基,烯基氧基,炔基氧基,烷氧基烷氧基,烷氧基烷基或烷氧基,其可被氯原子或羟基,氰基或氧代取代;含有一个或两个双键的环烷基或环烯基,该基团可以被一个或多个烷基取代。可以被一个或多个烷基取代的环烷基烷基,四氢糠基,四氢呋喃基或四氢吡喃基;三氟甲基;碳烷氧基烷基;环烷基烷氧基,环烷氧基或四氢呋喃基烷氧基;苯氧基,苯氧基烷氧基,苯氧基,苯烷基,苯基或萘基,其芳环可以被一个或多个烷基,烯基,烷氧基,硝基,三氟甲基,氰基,烷基磺酰基,酰基氨基和/或烷基磺酰基氨基和/或卤素取代原子或含杂芳族O和/或N的环系统;或R 5 是直链或支链的烷基或烯基;环烷基;芳烷基可以被一个或多个烷基,烯基,烷氧基,硝基,三氟甲基,氰基,酰基氨基,烷基磺酰基和/或烷基磺酰基氨基和/或氯,溴或氟原子取代的苯基烷基,苯基或萘基] ; R 3 ,R 7 和R 8 可以相同或不同,分别为氢或卤素原子或直链或支链烷基,烯基或烷氧基或氰基或三氟甲基; R 6 和R 9 可以相同或不同,分别为氢原子或烷基。 n为3、4或5;可以通过以下方法制备其盐:(a)使化合物(3)与其中W为氧或硫的内酰胺或硫代内酰胺(4)或其盐或反应性衍生物,特别是内酰胺反应; (b)使酰亚胺氯化物(6)与胺RNH 2反应; (c)使芳基异氰酸酯(8)与内酰胺(9)反应;(d)使氨基甲酰氯(10)与内酰胺(9)反应; (e)将其中R为氢的化合物(1)与其中B为反应性酯基或卤素的R-R和除氢以外的R-烷基烷基化; (f)使氨基苯基-环-(13)与酰化剂或磺化剂R SP 2 Y反应,其中Y是反应性酯基。中间体2-(4-氨基苯基-亚氨基)-1-甲基-吡咯烷可以通过2-(4-硝基苯基亚氨基)-1-甲基吡咯烷的催化氢化来制备。其他列出的中间体可以通过已知方法制备。化合物(1)的药物组合物显示出抗寄生虫药的活性,特别是抗蠕虫药的活性,并且一些当单独或与胃肠外一起口服或与常规赋形剂一起给药时具有抗高血压活性。

著录项

  • 公开/公告号IE35361B1

    专利类型

  • 公开/公告日1976-01-21

    原文格式PDF

  • 申请/专利权人 BAYER AG;

    申请/专利号IE19710000756

  • 发明设计人

    申请日1971-06-11

  • 分类号C07D295/00;C07D291/00;C07D211/18;A61K31/00;

  • 国家 IE

  • 入库时间 2022-08-23 02:53:59

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号